Login / Signup

Risk-stratification for treatment de-intensification in WNT-pathway medulloblastoma: finding the optimal balance between survival and quality of survivorship.

Tejpal GuptaShakthivel ManiAbhishek ChatterjeeArchya DasguptaSridhar EpariGirish Chinnaswamy
Published in: Expert review of anticancer therapy (2024)
Prospective clinical trials and emerging biological information should further refine risk-stratification in WNT-pathway medulloblastoma.
Keyphrases
  • clinical trial
  • cell proliferation
  • stem cells
  • healthcare
  • randomized controlled trial
  • quality improvement
  • health information
  • combination therapy
  • young adults
  • replacement therapy
  • double blind
  • phase iii